Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Regulatory News (VRP)

  • There is currently no data for VRP

Director's Dealing

10 Apr 2013 15:07

VERONA PHARMA PLC - Director's Dealing

VERONA PHARMA PLC - Director's Dealing

PR Newswire

London, April 10

Director's Dealing

10 April 2013 - London, UK - Verona Pharma plc (AIM: VRP.L) (the "Company") hasreceived notification that on 10 April 2013, Jan-Anders Karlsson, CEO and adirector of the Company, acquired 150,000 ordinary shares of 0.1p each in theCompany ("Ordinary Shares") at a price of 2.48 pence per share.

As a result, Dr. Karlsson is interested in 800,000 Ordinary Shares,representing approximately 0.1% of the Company's issued ordinary share capital.

-Ends-

For more information please contact:

Verona Pharma plc Tel: 020 7863 3300 Jan-Anders Karlsson, CEO info@veronapharma.com WH Ireland Limited Tel: 020 7220 1650 Chris Fielding chris.fielding@wh-ireland.co.uk
Date   Source Headline
23rd Aug 20067:01 amRNSRestoration - ISIS Resources
23rd Aug 20067:01 amRNSAcquisition and Placing
3rd May 200610:34 amRNSFinal Results
3rd Apr 20067:01 amRNSSuspension of shares
3rd Apr 20067:01 amRNSSuspension - ISIS Resources
9th Mar 20069:40 amRNSAppointment of NOMAD
28th Sep 200510:01 amRNSInterim Results
30th Aug 200511:29 amRNSConversion of Securities
31st May 20057:02 amRNSIssue of Equity
30th Mar 20059:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.